126 related articles for article (PubMed ID: 18282234)
1. Co-culture of head and neck squamous cell carcinoma spheroids with autologous monocytes predicts prognosis.
Kross KW; Heimdal JH; Olsnes C; Olofsson J; Aarstad HJ
Scand J Immunol; 2008 Apr; 67(4):392-9. PubMed ID: 18282234
[TBL] [Abstract][Full Text] [Related]
2. Head and neck squamous cell carcinoma spheroid- and monocyte spheroid-stimulated IL-6 and monocyte chemotactic protein-1 secretion are related to TNM stage, inflammatory state and tumor macrophage density.
Kross KW; Heimdal JH; Olsnes C; Olofsson J; Aarstad HJ
Acta Otolaryngol; 2005 Oct; 125(10):1097-104. PubMed ID: 16298793
[TBL] [Abstract][Full Text] [Related]
3. In vitro Monocyte IL-6 Secretion Levels Following Stimulation with Autologous Spheroids Derived from Tumour or Benign Mucosa Predict Long-term Survival in Head and Neck Squamous Cell Carcinoma Patients.
Aarstad HJ; Aarstad HH; Vintermyr OK; Kross KW; Lybak S; Heimdal JH
Scand J Immunol; 2017 Mar; 85(3):211-219. PubMed ID: 27943380
[TBL] [Abstract][Full Text] [Related]
4. Monocytes secrete interleukin-6 when co-cultured in vitro with benign or malignant autologous fragment spheroids from squamous cell carcinoma patients.
Heimdal J; Aarstad HJ; Olofsson J
Scand J Immunol; 2000 Mar; 51(3):271-8. PubMed ID: 10736096
[TBL] [Abstract][Full Text] [Related]
5. Viable head and neck tumor spheroids stimulate in vitro autologous monocyte MCP-1 secretion through soluble substances and CD14/lectin-like receptors.
Olsnes C; Heimdal JH; Kross KW; Olofsson J; Aarstad HJ
Eur Arch Otorhinolaryngol; 2005 Dec; 262(12):953-60. PubMed ID: 16328410
[TBL] [Abstract][Full Text] [Related]
6. Monocyte and monocyte-derived macrophage secretion of MCP-1 in co-culture with autologous malignant and benign control fragment spheroids.
Heimdal JH; Olsnes C; Olofsson J; Aarstad HJ
Cancer Immunol Immunother; 2001 Aug; 50(6):300-6. PubMed ID: 11570583
[TBL] [Abstract][Full Text] [Related]
7. Tumour-associated macrophages secrete IL-6 and MCP-1 in head and neck squamous cell carcinoma tissue.
Kross KW; Heimdal JH; Olsnes C; Olofson J; Aarstad HJ
Acta Otolaryngol; 2007 May; 127(5):532-9. PubMed ID: 17453481
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 predicts recurrence and survival among head and neck cancer patients.
Duffy SA; Taylor JM; Terrell JE; Islam M; Li Y; Fowler KE; Wolf GT; Teknos TN
Cancer; 2008 Aug; 113(4):750-7. PubMed ID: 18536030
[TBL] [Abstract][Full Text] [Related]
9. Human autologous monocytes and monocyte-derived macrophages in co-culture with carcinoma F-spheroids secrete IL-6 by a non-CD14-dependent pathway.
Heimdal JH; Aarstad HJ; Olsnes C; Olofsson J
Scand J Immunol; 2001 Feb; 53(2):162-70. PubMed ID: 11169220
[TBL] [Abstract][Full Text] [Related]
10. Stimulated monocyte IL-6 secretion predicts survival of patients with head and neck squamous cell carcinoma.
Heimdal JH; Kross K; Klementsen B; Olofsson J; Aarstad HJ
BMC Cancer; 2008 Jan; 8():34. PubMed ID: 18234094
[TBL] [Abstract][Full Text] [Related]
11. Presence of activated T lymphocytes in peripheral blood of head and neck squamous cell carcinoma patients predicts impaired prognosis.
Aarstad HJ; Heimdal JH; Klementsen B; Olofsson J; Ulvestad E
Acta Otolaryngol; 2006 Dec; 126(12):1326-33. PubMed ID: 17101596
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms for monocyte activation in co-culture with autologous tumor spheroids.
Olsnes C; Heimdal JH; Kross K; Olofsson J; Aarstad HJ
Cell Immunol; 2002 Sep; 219(1):11-21. PubMed ID: 12473263
[TBL] [Abstract][Full Text] [Related]
13. Three-dimensional culture and multidrug resistance: effects on immune reactivity of MCF-7 cells by monocytes.
Mougel L; Tarpin M; Albert P; Le Naour R; Devy J; Kaplan H; Ventéo L; Carlier A; Madoulet C
Anticancer Res; 2004; 24(2B):935-41. PubMed ID: 15161047
[TBL] [Abstract][Full Text] [Related]
14. Role of reactive oxygen species (ROS), metalloproteinase-2 (MMP-2) and interleukin-6 (IL-6) in direct interactions between tumour cell spheroids and endothelial cell monolayer.
Paduch R; Walter-Croneck A; Zdzisińska B; Szuster-Ciesielska A; Kandefer-Szerszeń M
Cell Biol Int; 2005 Jul; 29(7):497-505. PubMed ID: 15893483
[TBL] [Abstract][Full Text] [Related]
15. Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer.
Jebreel A; Mistry D; Loke D; Dunn G; Hough V; Oliver K; Stafford N; Greenman J
J Laryngol Otol; 2007 Mar; 121(3):246-52. PubMed ID: 17040593
[TBL] [Abstract][Full Text] [Related]
16. Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.
Aarstad HJ; Vintermyr OK; Ulvestad E; Aarstad HH; Kross KW; Heimdal JH
APMIS; 2015 Apr; 123(4):305-14. PubMed ID: 25801083
[TBL] [Abstract][Full Text] [Related]
17. Expression of IL-10 and IL-10 receptors on peripheral blood lymphocytes and monocytes in human head and neck squamous cell carcinoma.
Kato H; Whiteside TL
Tokai J Exp Clin Med; 2011 Dec; 36(4):144-51. PubMed ID: 22167499
[TBL] [Abstract][Full Text] [Related]
18. Recurrence in head and neck squamous cell carcinoma. Editorial.
Leibowitz MS; Ferris RL
Cancer; 2008 Aug; 113(4):671-3. PubMed ID: 18536028
[No Abstract] [Full Text] [Related]
19. Epidermoid carcinoma-cell culture supernatant's inhibition of monocyte chemotaxis: evidence for a tumour-mediated effect.
Güngör A; Yetgin S; Ustacelebi S; Sozeri B
J Otolaryngol; 1994 Aug; 23(4):229-33. PubMed ID: 7996619
[TBL] [Abstract][Full Text] [Related]
20. Flow cytofluorometric detection of tumor-specific rosette-forming cells in patients with squamous cell carcinoma of the head and neck.
Tong AW; Vanderbark AA; Kraybill W; Vetto RM; Burger DR
Cancer Res; 1982 Jul; 42(7):2949-55. PubMed ID: 6177400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
